TVM Capital has sold portfolio company DIREVO Biotech AG to Bayer HealthCare in an all cash deal valued at EUR 210m. DIREVO Industrial Biotechnology GmbH, a wholly owned subsidiary of DIREVO Biotech AG, is not subject to this transaction and has been sold in a separate deal to a group of financial investors.
De Scorbiac was responsible for the Accenture Venture fund's activities in Europe
GP sells the Dutch employment agency to its CEO, ending its three-years ownership
Financing for the acquisition was provided by Santander Corporate and Commercial Banking
Sussex Place Ventures, Contour Ventures, Partnership Fund and Outrun Ventures also take part